Summary
Some early psychiatrists already believed that schizophrenic disorders were associated with a disturbed balance of sexual hormones. This belief was based on the observation of a. an “insufficient functioning of the sexual glands” with so-called “hypoestrogenism”, and b. an influence of ovarian function on schizophrenic psychoses. As this review shows, there are findings from recent research which seem to confirm that estrogens may have a protective effect in schizophrenia. There are also occasional hints at a possible “hypoestrogenism” in schizophrenia. In our own epidemiological, clinical and animal studies the hypothesis of a protective effect of oestrogens was for the first time systematically examined and confirmed. Oestrogens seem to modulate the sensitivity of D2-receptors in the brain, and clinically they seem to have a neuroleptic-like effect. These findings may have important implications for the prevention and therapy of schizophrenic disorders. Furthermore, our findings indicate the need to reinvestigate the question of a disturbed balance of sexual hormones in schizophrenic disorders. Further research on the role of oestrogens in schizophrenic disorders could in our opinion contribute to understanding the still unclear, possibly aetiologically heterogeneous pathogenetic mechanism of schizophrenic psychoses.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baruk H, Melzer R, Vezous A, Farjeat J (1950) L'effondrement oestrogénique dans la démence precoce. Etude par la méthode des frottis vaginaux de Papanicolaou. Ann of Medical Psychol (Paris) 108:181–187
Bédard P, Langelier P, Villeneuve A (1977) Estrogens and the Extrapyramidal System. Lancet II:1367–1368
Bédard P, Boucher R, Daigle M, DiPaolo T (1984) Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys. Psychoneuroendocrinology 9:375–379
Beumont PJ, Gelder MG, Friesen HG, Harris GW, McKinnon PC, Mandelbrote BM, Wiles DH (1974) The effects of phenothiazines on endocrine function: Patients with inappropriaqte lactation and amenorrhea. Br J Psychiatry 124:413–419
Bleuler M (1943) Die spätschizophrenen Krankheitsbilder. Neurologie XV, 9:259–290
Brambilla F, Guerrini A, Guastalla A, Rovere C, Riggi F (1975) Neuroendocrine Effect of Haloperidol Therapy in Chronic Schizophrenia. Psychopharmacologia 44:17–22
Brambilla F (1980) Neuroendocrine function in schizophrenia. Acta Psychiatria Belg 80:421
Carlsson A (1987) The dopamine hypothesis of schizophrenia 20 years later. In: Häfner H; Gattaz WF; and Janzarik W (eds) Search for the causes of schizophrenia. Springer, Berlin Heidelberg New York, pp 223–235
Chang SS, Renshaw DC (1986) Psychosis and pregnancy. Compr Ther 12:36–41
Collu R, Jequier JC, Leboeuf J, Ducharme JR (1977) Endocrine effects of pimozide, a specific dopaminergic blocker. J Endocrinol Metab 44:981–948
Cookson JC (1981) Oestrogens, dopamine and mood. Br J Psychiatry 139:365
Czernik A, Kleesiek K (1979) Die Wirkung von Depotneuroleptika auf die Hormonsekretion des Hypophysen-Vorderlappens. Nervenarzt 50:527–533
Diczfalusy E, Lauritzen C (1961) Östrogene beim Menschen. Springer, Berlin Göttingen Heidelberg
Diedrich K, Wildt L (1990) Neue Wege in Diagnostik und Therapie der Sterilität. Enke, Stuttgart
DiPaolo T, Payet P, Labrie F (1981) Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors. Eur J Pharmacol 73:105–106
Dupont A, DiPaolo T, Gagne B, Barden N (1981) Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats. Neurosci Let 22:69–74
Endo M, Daiguji M, Asano Y, Yamashita I, Takahashi S (1978) Periodic Psychosis recurring in Association with Menstrual Cycle. J Clin Psychiatry 39:456–466
Ferrier IN, Johnstone EC, Crow TJ, Rinzcon-Rodriguez I (1983) Anterior pituitary hormone secretion in chronic schizophrenics: responses to administration of hypothalamic releasing hormones. Arch Gen Psychiatry 40:755
Foreman MM, Porter JC (1980) Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity. J Neurochem 34:1175–1183
Gattaz WF, Behrens S, De Vry J, Häfner H (1991) Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten: ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr Neurol Psychiatr 1:1–44
Geller EC (1923) Über Eierstocksfunktion bei Dementia praecox auf Grund anatomischer Untersuchungen. Arch Gynae 120:237
Glick J, Stewart D (1980) A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 21:281–287
Goldstein MJ, Rodnick FH, Evans JR, May PRA, Steinberg MR (1978) Drugs and family therapy in the aftercare of acute schizophrenics. Arch Gen Psychiatry 35:1169–1177
Gordon JH, Diamond BI (1981) Antagonism of dopamine supersensivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia. Biol Psychiatry 16:365–371
Gordon JH, Borison RL, Diamond BI (1980) Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 15:389–396
Häfner H (1987) Epidemiology of Schizophrenia. In: Häfner H, Gattaz WF, Janzarik W (eds) Search for the causes of schizophrenia, vol I. Springer, Berlin Heidelberg New York
Häfner H, Riecher A, Maurer K, Löffler W, Munk-Jørgensen P, Strömgren E (1989) How does gender influence age at first hospitalization for schizophrenia? Psychol Med 19:903–918
Häfner H, Behrens S, De Vry J, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991a) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogen. Nervenheilk 10:154–163
Häfner H, Behrens S, De Vry J, Gattaz WF (1991b) An animal model for the effects of estradiol on dopamine-mediated behaviour: implications for sex differences in schizophrenia. Psychiatry Res 38:125–134
Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, Heiden W an der (1991c) Geschlechtsunterschiede bei schizophrenen Erkrankungen. Fortsch Neurol Psychiatr 59:343–360
Hogarty GE, Goldberg SC, Schooler NR, Ulrich RF (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 31:603–618
Holsboer F, Benkert O, Demisch L (1983) Changes in MAO activity during estrogen treatment of females with endogenous depression. Mod Probl Pharmacopsychiatry 19:321–326
Hruska RE, Silbergeld EK (1980) Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum. Eur J Pharmacol 61:397–400
Kane JM, Cooper TB, Sachar EJ, Halpern FS, Bailine S (1981) Clozapine: plasma levels and prolactin response. Psychopharmacology 73:184
Kendell RE, Chalmers JC, Platz C (1987) Epidemiology of puerperal psychoses. Br J Psychiatry 150:662–673
Koller WC, Weiner WJ, Klawans HL, Nausieda PA (1980) Influence of female sex hormones on neuroleptic-induced behavioral supersensitivity. Neuropharmacology 19:387–391
Kraepelin E. (1909–1915) Psychiatrie, Bd 1–4. Barth, Leipzig
Krafft-Ebing G von (1896) Untersuchungen über Irresein zur Zeit der Menstruation: Ein klinischer Beitrag zur Lehre vom periodischen Irresein. Arch Psychiatr 8:65–107
Kretschmer E (1921) Körperbau und Charakter. Untersuchungen zum Konstitutionsproblem und zur Lehre von den Temperamenten. 25th edition 1967. Springer, Berlin Heidelberg New York
Lewine RRJ (1988) Gender and Schizophrenia. In: Nashrallah HA (ed) Handbook of schizophrenia, vol 3. Elsevier, New York, pp 121–136
Lobo RA, Shoupe D, Roy S, Paul W (1984) Central and peripheral metabolites of norepinephrine and dopamine in postmenopausal women. Am J Obstet Gynecol 5:548–552
Maggi A, Perez J (1985) Minireview: role of female gonodal hormones in the CNS; clinical and experimental aspects. Life Sci 37:893–906
Mall G (1959) Neuere Ergebnisse der Psycho-Endokrinologie. Ärztl Prax XI/40:1357–1360
Mall G (1960) Diagnostik und Therapie ovarieller Psychosen. Zentralbl Gesamte Neurol Psychiatr 155:250
Naber D, Ackenheil M, Laakman G, Fischer H, von Werder K (1980) Basal and stimulated levels of prolactin, TSH and LH in serum of chronic schizophrenic patients, long-term treated with neuroleptics. Pharmakopsychiatry 13:325–330
Nicoletti F, Ferrara N, Patti F, Viglianesi M, Rampello L, Bianchi A, Reggio A, Scapagnini U (1983) Influence of sex steroids and prolactin on haloperidol-induced catalepsy. Brain Res 279:352–358
Nott PN (1982) Psychiatric illness following childbirth in Southampton: A case register study. Psychological Med 12:557–561
Prentice DS, Deakin JFW (1992) Role of neuroleptic drugs and organic mechanism in the aetiology of menstrual irregularities in women. Schizophr Res 6(2):114
Riecher A, Maurer K, Löffler W, Fätkenheuer B, an der Heiden W, Häfner H (1989) Schizophrenia — a Disease of Young Single Males? Eur Arch Psychiatry Neuroll Sci 239:210–212
Riecher A, Maurer K, Löffler W, Fätkenheuer B, an der Heiden W, Munk-Jørgensen P, Strömgren E, Häfner H (1991) Sex differences in age at onset and course of schizophrenic disorders — a contribution to the understanding of the disease? In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol 2. Springer, Berlin Heidelberg New York, pp 14–33
Riecher-Rössler A, Häfner H, Stummbaum M, Maurer K, Schmidt R (1993) Can estradiol modulate schizophrenic symptomatology? Schizophrenia Bull (in press)
Seeman MV (1981) Gender and the Onset of Schizophrenia: Neurohumoral Influences. Psychiatr J Univ Ottawa 6:136–138
Seeman MV (1983) Interaction of sex, age, and neuroleptic dose. Compr Psychiatry 24:125–128
Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophrenia Bull 16:185–194
Villeneuve A, Cazejust T, Cote M (1980) Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 6:145–151
Wieck A (1989) Endocrine aspects of postnatal mental disorders. Baillière's Clinical Obstetrics and Gynaecology 3:857–877
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riecher-Rössler, A., Häfner, H. Schizophrenia and oestrogens — is there an association?. Eur Arch Psychiatry Clin Nuerosci 242, 323–328 (1993). https://doi.org/10.1007/BF02190244
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02190244